Vivo Bio Tech Complete Financial Statements
In FY2026, Vivo Bio Tech (VIVOBIOT) reported revenue ₹14 Cr, net profit ₹-5 Cr and EPS ₹-2.52, with a net profit margin of -35.7% and ROE of -5.4%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse VIVOBIOT FII DII holdings to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
VIVOBIOT Revenue, Net Profit & EBITDA — Year-on-Year Growth
VIVOBIOT YoY (Mar 2025 vs Mar 2026) — revenue +16.7%, net profit -600.0%, expenses +42.9%. Examine Vivo Bio Tech quarterly earnings for recent quarterly revenue, profit and EPS trends.
VIVOBIOT Income Statement — Revenue, EBITDA & Net Profit
Vivo Bio Tech revenue ₹14 Cr, EBITDA ₹5 Cr, net profit ₹-5 Cr, EPS ₹-2.52 (2026) — net profit margin -35.7%. For live price, earnings ratios and company overview, see Vivo Bio Tech share price today.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 13 | 12 | 13 | 14 | 17 | 12 | 10 | 12 | 9 | 15 | 12 | 13 | 13 | 15 | 11 | 14 | 10 | 16 | 13 | 13 | 15 | 14 | 9 | 12 | 14 | 14 | 13 | 14 | 14 | 12 | 14 |
| Expenses | 10 | 8 | 7 | 7 | 8 | 6 | 6 | 6 | 7 | 4 | 8 | 7 | 7 | 8 | 14 | 7 | 9 | 6 | 12 | 7 | 7 | 9 | 13 | 6 | 7 | 10 | 15 | 10 | 10 | 10 | 10 | 11 |
| EBITDA | 5 | 6 | 5 | 6 | 6 | 10 | 5 | 4 | 6 | 5 | 7 | 5 | 6 | 5 | 2 | 5 | 5 | 4 | 4 | 6 | 6 | 6 | 1 | 3 | 5 | 4 | -1 | 4 | 4 | 4 | 3 | 3 |
| Operating Profit Margin % | 31.00% | 41.00% | 41.00% | 44.00% | 41.00% | 47.00% | 46.00% | 43.00% | 45.00% | 52.00% | 48.00% | 39.00% | 50.00% | 37.00% | 11.00% | 42.00% | 36.00% | 38.00% | 25.00% | 44.00% | 45.00% | 41.00% | 9.00% | 31.00% | 40.00% | 27.00% | -9.00% | 28.00% | 27.00% | 28.00% | 22.00% | 22.00% |
| Depreciation | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Interest | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 0 | 2 | 1 | 2 | 2 | 6 | 1 | 0 | 2 | 1 | 3 | 0 | 2 | 1 | -2 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | -1 | 1 | 3 | 2 | -3 | 2 | 2 | 2 | 1 | 1 |
| Tax | 5 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | -1 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 0 | 0 | 1 | -1 | 0 | 0 | 0 | -1 | 0 | 0 |
| Net Profit | -5 | 1 | 1 | 1 | 1 | 5 | 1 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 0 | 1 | 2 | 2 | -3 | 1 | 1 | 3 | 1 | 1 |
| Earnings Per Share (₹) | -2.52 | 0.45 | 0.69 | 0.74 | 0.56 | 3.51 | 0.50 | 0.11 | 0.55 | 0.22 | 1.38 | 0.10 | 0.89 | 0.08 | -0.49 | 0.22 | 0.10 | 0.20 | 0.22 | 0.87 | 0.97 | 1.63 | -0.31 | 0.76 | 1.73 | 1.83 | -2.41 | 0.94 | 1.02 | 2.48 | 0.82 | 1.27 |
VIVOBIOT Balance Sheet — Assets, Liabilities & Shareholders' Equity
VIVOBIOT total assets ₹178 Cr, total equity ₹92 Cr, total liabilities ₹ Cr (2026) — ROE -5.4%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 178 | 143 | 137 | 123 | 123 | 80 | 64 | 55 | 60 | 51 | 46 | 41 |
| Current Assets | 28 | 42 | 47 | 32 | 26 | 27 | 27 | 25 | 28 | 20 | 22 | 22 |
| Fixed Assets | 128 | 88 | 80 | 89 | 95 | 52 | 35 | 30 | 28 | 29 | 24 | 20 |
| Capital Work in Progress | 5 | 13 | 9 | 2 | 1 | 0 | 0 | 0 | 4 | 3 | 0 | 0 |
| Investments | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 42 | 48 | 32 | 26 | 27 | 29 | 25 | 28 | 20 | 22 | 22 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 55 | 38 | 45 | 46 | 52 | 15 | 10 | 9 | 15 | 22 | 15 | 4 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 92 | 78 | 54 | 52 | 47 | 43 | 33 | 27 | 19 | 13 | 10 | 9 |
| Share Capital | 22 | 17 | 15 | 15 | 14 | 13 | 13 | 12 | 10 | 9 | 9 | 9 |
| Reserves & Surplus | 69 | 54 | 40 | 37 | 32 | 28 | 20 | 15 | 7 | 3 | 1 | 0 |
VIVOBIOT Cash Flow Statement — Operating, Investing & Financing
Vivo Bio Tech operating cash flow ₹12 Cr, investing ₹-16 Cr, financing ₹4 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 12 | 16 | 15 | 17 | 14 | 9 | -1 | 11 | -6 | 9 | 2 |
| Investing Activities | -16 | -8 | -4 | -51 | -23 | -10 | -4 | -5 | -12 | -7 | -2 |
| Financing Activities | 4 | -8 | -11 | 35 | 9 | 2 | 1 | -3 | 7 | 0 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 1 | 0 | 1 | -4 | 3 | -11 | 1 | -1 |